ORPHAZYME INTERIM REPORT FIRST HALF 2019 PRESENTATION

Copenhagen, Denmark, August 21, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announces that the Company will be hosting an investor call at which Chief Executive Officer, Anders Hinsby, and Chief Financial Officer, Anders Vadsholt, will be presenting the Interim Report First Half 2019. The presentation will be followed by a Q&A session.

 

The call will be held on: Wednesday, August 28, 2019 at 11.00 AM CEST/5.00 AM EDT.

 

Dial-in details:

·       Denmark: +45 32 72 80 42

·       United Kingdom: +44 (0) 844 571 88 92

·       United States: +1 6315 107 495


Event Title: Orphazyme Interim Report First Half 2019

 

Confirmation code: 8655918

 

The presentation will also be available via webcast: https://edge.media-server.com/mmc/p/v2haoix5

 

After the call, the presentation will be available via the webcast link above.